The actions of valproate and neurosteroids in a model of trigeminal pain

Headache

Volumn 36, Issue 10, 1996, Pages 579-585

  Cutrer, F Michael ^a   Moskowitz, Michael A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

allopregnanolone; c fos; capsaicin; GABA; migraine; valproate

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; BICUCULLINE; CAPSAICIN; IRRITANT AGENT; PHACLOFEN; PROGESTERONE DERIVATIVE; STEROID; VALPROIC ACID; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; ELTANOLONE; GABAERGIC RECEPTOR AFFECTING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GUINEA PIG; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ONCOGENE C FOS; PAIN; PRIORITY JOURNAL; TRIGEMINAL NUCLEUS; TRIGEMINUS NEURALGIA; ANIMAL; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION; GENETICS; HEADACHE; ONCOGENE; PATHOPHYSIOLOGY;

ANIMALS; CAPSAICIN; DISEASE MODELS, ANIMAL; GABA AGENTS; GABA MODULATORS; GENE EXPRESSION; GENES, FOS; GUINEA PIGS; HEADACHE; MALE; PAIN; PREGNANOLONE; RECEPTORS, GABA; VALPROIC ACID;

EID: 0030277221     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1996.3610579.x     Document Type: Article

References (39)

1. Hering R, Kuritzky A. Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia. 1992;12:81-84.
2. Jensen R, Brinck T, Olesen J. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology. 1994;44:647-651.
3. Coria F, Sempere AP, Duarte J, Claveria LE, Cabezas C, Bayon C. Low-dose sodium valproate in the prophylaxis of migraine. Clin Neuropharmacol. 1994;17:569-573.
4. Hering R, Kuritzky A. Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia. 1989;9:195-198.
5. Godin Y, Heiner L, Mark J, Mandel P. Effects of di-n-propylacetate, and anticonvulsive compound, on GABA metabolism. J Neurochem. 1969;16:869-873.
6. Loscher W. Valproate induced changes in GABA metabolism at the subcellular level. Biochem Pharmacol. 1981;30:1364-1366.
7. A receptor channels. Annu Rev Neurosci. 1994;17:569-602.
8. B receptors. Trends Pharmacol Sci. 1993;14:259-261.
9. Dragunow M, Robertson HA. Kindling stimulation induces c-fos protein(s) in granule cells of rat dentate gyrus. Nature. 1988;329:441-442.
10. Uemura Y, Kowall NW, Moskowitz MA. Focal ischemia in rats causes time-dependent expression of c-fos protein immunoreactivity in widespread regions of ipsi-lateral cortex. Brain Res. 1991;552:99-105.
11. Morgan JI, Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci. 1991;14:421-451.
12. Hunt SP, Pini A, Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature. 1987;328:632-634.
13. Menetrey D, Gannon A, Levine JD, Basbaum AI. Expression of c-fos protein in interneurons and projection neurons of the rat spinal cord in response to noxious somatic, articular, and visceral stimulation. J Comp Neurol. 1989;285:177-195.
14. Presley RW, Menetrey D, Levine JD, Basbaum AI. Systemic morphine suppresses noxious stimulus-evoked fos protein-like immunoreactivity in the rat spinal cord. J Neurosci. 1990;10:323-335.
15. Nozaki K, Boccalini P, Moskowitz MA. Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space. Neuroscience. 1992;49(3):669-680.
16. Nozaki K, Moskowitz MA, Boccalini P. CP-93, 129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Br J Pharmacol. 1992;106:409-415.
17. Cutrer FM, Moussaoui S, Garret C, Moskowitz MA. The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation. Neuroscience. 1995;64:741-750.
18. Cutrer FM, Schoenfeld D, Limmroth V, Panahian N, Moskowitz, MA. Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br J Pharmacol. 1995;114:987-992.
19. A receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation. Br J Pharmacol. 1995;116: 1661-1667.
20. Szabat E, Soinila S, Happola O, Linnala A, Virtanen I. A new mononclonal antibody against the GABA-protein conjugate shows immunoreactivity in sensory neurons of the rat. Neuroscience. 1992;47:409-420.
21. Hamel E, Krause D, Roberts E. Glutamicacid decarboxylase activity in intracerebral blood vessels. J Cereb Blood Flow Metab. 1983;3(suppl):S198-S199.
22. Imai H, Okuno T, Wu JY, Lee TJ. GABAergic innervation in cerebral blood vessels: an immunohistochemical demonstration of L-glutamic acid decarboxylase and GABA transaminase. J Cereb Blood Flow Metab. 1991;11:129-134.
23. Barber RP, Vaughn JE, Roberts E. The cytoarchitecture of GABAergic neurons in rat spinal cord. Brain Res. 1982;238:305-328.
24. Carlton SM, Hayes ES. Light microscopic and ultrastructural analysis of GABA-immunoreactive profiles in the monkey spinal cord. J Comp Neurol. 1990;300:162-182.
25. Magoul R, Onteniente B, Geffard M, Calas A. Anatomical distribution and ultrastructural organization of the GABAergic system in the rat spinal cord. An immunocytochemical study using anti-GABA antibodies. Neuroscience. 1987;20:1001-1009.
26. Palacios JM, Wamsley JK, Kuhar MJ. High affinity GABA receptors-autoradiographic localization. Brain Res. 1981;222:285-307.
27. B receptor site distribution in the rat central nervous system. Neuroscience. 1987;20:365-383.
28. Waldvogel HJ, Faull RL, Jansen KL, et al. GABA, GABA receptors and benzodiazepine receptors in the human spinal cord: an autoradiographic and immunohistochemical study at the light and electron microscopic levels. Neuroscience. 1990;39:361-385.
29. Basbaum AI, Glazer EJ, Oertel W. Immunoreactive glutamic acid decarboxylase in the trigeminal nucleus caudalis of the cat: a light- and electron-microscopic analysis. Somatsens Res. 1986;4:77-94.
30. Hammond DL, Drower EJ. Effects of intrathecally administered THIP, baclofen, and muscimol on nociceptive threshold. Eur J Pharmacol. 1984;103:121-125.
31. Roberts LA, Beyer C, Komisaruk BR. Nociceptive responses to altered GABAergic activity at the spinal cord. Life Sci. 1986;39:1667-1674.
32. Dickenson AH, Brewer CM, Hayes NA. Effects of topical baclofen on C fibre-evoked neuronal activity in the rat dorsal horn. Neuroscience. 1985;14:557-562.
33. B receptor antagonist in rats. J Pharmacol Exp Ther. 1994;271:76-82.
34. Singh I, Singh I, Singh D. Progesterone in the treatment of migraine. Lancet. 1947;i:745-747.
35. Bradley WG, Hudgson PB, Foster JB, Newell DJ. Double-blind controlled trial of a micronized preparation of flumdroxone (Demigran) in prophylaxis of migraine. Br Med J. 1968;3:531-533.
36. Lundberg PO. Prophylactic treatment of migraine with flumendroxone. Acta Neurol Scand. 1969;45:309-326.
37. Honore P, Chapman V, Buritova J, Besson JM. Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor. Br J Pharmacol. 1995;114:77-84.
38. Anton F, Herdegen T, Peppel P, Lean JD. C-Fos-like immunoreactivity in rat brainstem neurons following noxious chemical stimulation of the nasal mucosa. Neuroscience. 1991;41:629-641.
39. Bullitt E. Expression of C-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J Comp Neurol. 1990;296:517-530.